Workflow
Solesence Inc(SLSN) - 2024 Q2 - Quarterly Report
Solesence IncSolesence Inc(US:SLSN)2024-08-10 04:24

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended: June 30, 2024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to _______ to _______ Commission File Number: 000-22333 Nanophase Technologies Corporation (Exact name of registrant as specified in its charter) 1319 Marquette Drive, R ...